Anaemia and the heart.

Area of Science:

• Cardiology
• Hematology

Background:

• Anemia is prevalent in congestive heart failure (CHF) patients, increasing with disease severity.
• Causes include renal insufficiency, inflammation, blood loss, iron deficiency, malnutrition, and fluid overload.
• Anemia can exacerbate CHF and is linked to adverse outcomes in cardiovascular conditions.

Purpose of the Study:

• To summarize the impact of anemia on patients with cardiovascular disease.
• To highlight the association between anemia and mortality in various cardiac scenarios.
• To identify the need for further multicenter trials.

Main Methods:

• Literature review and synthesis of existing research on anemia in cardiovascular disease.
• Analysis of data concerning mortality rates in patients with anemia and cardiovascular disease undergoing surgery.
• Examination of the relationship between hemoglobin levels and survival.

Main Results:

• Anemia is associated with increased in-hospital events and mortality after acute myocardial infarction, coronary bypass surgery, and percutaneous coronary interventions.
• Patients with both anemia and cardiovascular disease face higher mortality risks after surgery.
• A U-shaped curve describes the nonlinear relationship between hemoglobin and survival.

Conclusions:

• Anemia is a significant comorbidity in cardiovascular disease, associated with poorer prognosis.
• Further multicenter trials are essential to definitively clarify the impact of anemia on mortality in cardiovascular patients.
• Recombinant human erythropoietin shows potential pleiotropic effects beyond hematocrit increase.